Answers are grounded in this paper and cite their sources.
Infantile Ewing Sarcoma (ES) is an extremely rare disease with comparable outcomes on contemporary protocols with a paucity of data from India. Infants with proven ES diagnosed between January 2012 and December 2020 were retrospectively analyzed. The staging was done using positron emission tomography-computerized tomography scan. Treated infants were administered weight-based chemotherapy with local control by surgery and/or radiotherapy. There were 10 infantile ES with a male-to-female ratio of 2.3:1. The majority had extraosseous (90%, n=9) or axial primary (50%, n=5). Five patients with localized disease received treatment. Two died during induction chemotherapy (sepsis-1, cause unknown-1), and 3 are alive with no evidence of disease at a median follow-up of 8 years (range, 4-9 years). Two episodes of complicated febrile neutropenia were reported in 5 treated infants. ES in infants is rare and predominantly extraosseous with axial primary. Treated infants tolerated chemotherapy well with good outcomes.
No takes yet. Share an insight, caveat, or question.
Parambil et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: